Report Overview

The global neurodiagnostics market was worth USD 6.7 billion in 2020 and is further projected to reach USD 11.4 billion by the year 2027, growing at a CAGR of 8.0% during the forecast period. Major factors driving the growth of the market are the increasing prevalence of neurodegenerative diseases, the increasing number of diagnostic centers, and the growing awareness of early diagnosis for effective treatment. Additionally, R&D activities in imaging technologies and neurodiagnostics are projected to drive business growth in the next few years.

Source: BlueWeave Consulting

Global Neurodiagnostics Market- Overview

Neurodiagnostics is a specialized test that helps in the diagnosis of neurological conditions. During this type of examination, the central nervous system is analyzed for accurate diagnosis which ensures that effective treatment can be provided to the patient.Tests are performed to determine if the brain, spinal cord, or peripheral nervous system is functioning properly. Neurodiagnostics testings are of two types— Imaging Tests &Scans (MRI, PET scan, CT scan, x-ray) and electrical impulse detection (EEG and EMG).

Global Neurodiagnostics Market Forecast and Trends

Growth Drivers

Increasing Prevalence of Neurodegenerative Diseases

The global burden of neurological and neurodegenerative diseases has led to an increased demand for the effective diagnosis of these diseases. According to the WHO, neurological disorders account for 12% of all deaths around the world. Moreover, it has been estimated that there are 276 million people worldwide who suffer from several disorders such as Alzheimer’s, strokes, epilepsy, migraine, etc. In the coming years, the market for neurodiagnostics will be a prospecting and lucrative market around the world due to the increasing incidence of neurological disorders and the growing need for early diagnosis.

Technological Advancements in The Neurodiagnostics

Diagnostic imaging manufacturers are investing significantly in bringing technological advancements into their modalities that can accurately assist in the diagnosis of neurological disorders. For instance, the StealthStation S8 Neurosurgery System, a product of Medtronic PLC, offers clear visualization and surgical navigation of every segment of the spine. It consists of technologies like 3D cameras, electromagnetic sensors, tracking algorithms, software for data processing, and much more. Such technologies streamline the entire diagnostic process, thereby driving the growth of the global neurodiagnostic market.

Restraints

High Cost of Diagnosis and Imaging Technologies

Adoption of imaging technologies requires heavy investment, and the high cost of these technologies imposes a limitation on theiradoption, especially within healthcare facilities of developing and low-income countries. A typical ultrasound machine can cost between USD 20,000 and USD 200,000, with some machines costing even more. A PET scanner, on the other hand, costs around USD 2 million, whereas MRI scanners cost around USD 1 million. These amounts are considered to be extremely expensive, which restricts adoption and limits the market growth. Other than high pricing, other major challenges restraining the growth of the global neurodiagnostics market are the installation and maintenance of the neurodiagnostics devices.

Impact of COVID-19 on Global Neurodiagnostics Market

The COVID-19 pandemic brought an immense burden on the entire healthcare system. Lack of medical resources was exacerbating the COVID-19 outbreak, and more people were being infected every day. Because of this, the healthcare facilities started investing significantly towards the accumulation of respiratory support devices such as life support machines, oxygen generators, ventilators, PPE kits, masks, and gloves, etc. As a result, the demand for the neurodiagnostic market declined significantly, affecting the overall global neurodiagnostic market negatively. Furthermore, the manufacturing of such devices was also affected due to lockdown and social distancing protocols, due to which the manufacturers had to incur severe losses.

Global Neurodiagnostics Market - By Product

Based on products, the global neurodiagnostic market is segmented into diagnostic imaging systems, clinical diagnostic instruments, and reagents & consumables. The diagnostic imaging systems segment captured the largest market share in 2020. This segment is further classified into ultrasound imaging systems, EEG systems, MEG devices, MRI systems, angiography systems, PET scanners, CT scanners, EMG devices, and other diagnostic imaging systems. Currently, the demand for MRI systems, PET scanners, and CT scanners is very prominent in healthcare facilities as these systems play an important role in the diagnosis of brain malfunction, genetic metabolic disorders, mental disorders, and much more.

Global Neurodiagnostics Market - By Application

Based on applications, the global neurodiagnostic market is categorized into neurodegenerative diseases, headache disorders, stroke, sleep disorders, and epilepsy. Among these, the neurodegenerative diseases segment currently holds the largest market share. The prevalence of several neurodegenerative diseases, such as Alzheimer’s, spinal muscular atrophy, Lewy body disease, Friedreich ataxia, etc., has witnessed a sharp surge in its cases over the last few years. Moreover, Alzheimer’s is said to be the most frequent cause of dementia in Western countries and affects around 24 million people worldwide. Due to this, the demand for neurodiagnostic tests is projected to rise in the forecast period.

Global Neurodiagnostics Market - Regional Insights

Geographically, the global neurodiagnostic market is segmented into North America, Europe, Asia-Pacific, Latin America, Middle-East & Africa. Among all the regions, North America dominates the market because of the developed healthcare infrastructure and high awareness of neurological and neurodegenerative diseases in the region. Moreover, favorable reimbursement policies in developed countries like the United States offer significant coverage for neuropsychological tests and also favor the neurodiagnostic market. In the United States, psychological and neuropsychological tests are covered by Medicare Part B under Section 1861(s)(3) of the Social Security Act.

Source: BlueWeave Consulting

Competitive Landscape

The leading market players in the global Neurodiagnostics market are Nihon Kohden Corporation, GE Healthcare, Canon Medical Systems Corporation, Hoffman-La Roche AG, Advanced Brain Monitoring, Inc, FUJIFILM Holdings Corporation, Siemens Healthineers, Hoffman-La Roche AG, Lifelines Neuro Company, Bio-Rad Laboratories, Koninklijke Philips N.V., QIAGEN N.V., Natus Medical Incorporated, Fujirebio, Thermo Fisher Scientific, Inc, Agilent Technologies, Hitachi, Ltd, Ridge Diagnostics, Bruker, and other prominent players.

The market is highly competitive and dense with the presence of several global industry leaders such as Philips, GE Healthcare, FUJIFILM, etc. For expanding their portfolio, the companies have been investing heavily in R&D activities, advancements, and innovation. There is intense competition in the market also because the market players are focusing on developing innovative products to build their product portfolios. Furthermore, the adoption of competitive strategies like partnership, mergers, acquisitions, and collaboration is also very prominent in this market. The market players will face greater competition as technology develops and upgrades in the coming years.

Recent Developments

• In May 2021, Sense Neuro Diagnostics, a US-based medical tech startup, announced its strategic collaboration with Inflect Health, a venture capital health, for the development of devices for improving outcomes of stroke and brain injury patients.
• In December 2021, Rhythmlink International LLC, a US-based medical equipment manufacturer, announced the acquisition of Chalgren Enterprises (a medical device manufacture), to expand its product portfolio of brain and nervous system monitoring.

Scope of the Report

By Product

• Diagnostic Imaging Systems

• Ultrasound Imaging Systems
• EEG Systems
• MEG Devices
• MRI Systems
• Angiography Systems
• PET Scanners
• CT Scanners
• EMG Devices
• Other Diagnostic Imaging Systems

• Clinical Diagnostic Instruments

PCR Instruments

• NGS Instruments
• Sanger Sequencers
• Other Clinical Diagnostic Instruments
• Reagents & Consumables

• Reagents & Consumables

• Media & Sera
• Probes
• Antibodies
• Enzymes, Proteins, & Peptides
• Buffers
• Solvents
• Other Reagents & Consumables

By Application

• Neurodegenerative Diseases
• Headache Disorders
• Stroke
• Sleep Disorders
• Epilepsy

By End-User

• Hospitals & Surgical Centers
• Ambulatory Care Settings
• Diagnostic Laboratories & Imaging Centers
• Neurology Centers
• Academic & Research Institutes

By Region

• North America
• Europe
• Asia-Pacific (APAC)
• Latin America (LATAM)
• Middle-East & Africa (MEA)

1. Research Framework
   1. Research Objective
   2. Product Overview
   3. Key Market Segments
2. Research Methodology
   1. Qualitative Research
   2. Methodology
   3. Regional Split of Primary & Secondary Research
   4. Secondary Research
   5. Primary Research
      1. Breakdown of Primary Research Respondents, By Region
      2. Breakdown of Primary Research Respondents, By Industry Participants
   6. Market Size Estimation
   7. Assumptions for the Study
   8. Market Breakdown & Data Triangulation
3. Executive Summary
4. Industry Insight and Growth Strategy
   1. Value Chain Analysis
   2. DROC Analysis
      1. Market Drivers
         1. Increasing Prevalence of Neurodegenerative Diseases
         2. Technological Advancements in The Neurodiagnostics
         3. Neuroimaging Techniques
      2. Market Restraints
         1. High Cost of Diagnosis and Imaging Technologies
      3. Market Challenges
         1. 1. Use of refurbished Products
      4. Market Opportunity
         1. The Ongoing Covid-19 Pandemic
         2. Increasing Research and Development Activities
   3. Recent Developments
   4. Porter’s Five Forces Analysis
      1. Bargaining Power of Buyers
      2. Bargaining Power of Suppliers
      3. Intensity of Rivalry
      4. Threat of New Entrants
      5. Threat of Substitutes
5. Global Neurodiagnostics Market Overview
   1. Market Size & Forecast by Value, 2017-2027
   2. Market Size and Forecast, By Segment
      1. By Product
         1. Diagnostic Imaging Systems
            1. Ultrasound Imaging Systems
            2. EEG Systems
            3. MEG Devices
            4. MRI Systems
            5. Angiography Systems
            6. PET Scanners
            7. CT Scanners
            8. EMG Devices
            9. Other Diagnostic Imaging Systems
         2. Clinical Diagnostic Instruments
            1. PCR Instruments
            2. NGS Instruments
            3. Sanger Sequencers
            4. Other Clinical Diagnostic Instruments
         3. Reagents & Consumables
            1. Media & Sera
            2. Probes
            3. Antibodies
            4. Enzymes, Proteins, & Peptides
            5. Buffers
            6. Solvents
            7. Other Reagents & Consumables
      2. By Application
         1. Neurodegenerative Diseases
         2. Headache Disorders
         3. Stroke
         4. Sleep Disorders
         5. Epilepsy
      3. By End-user
         1. Hospitals & Surgical Centers
         2. Ambulatory Care Settings
         3. Diagnostic Laboratories & Imaging Centers
         4. Neurology Centers
         5. Academic & Research Institutes
      4. By Region
         1. North America
         2. Europe
         3. Asia-Pacific
         4. Latin America
         5. Middle East & Africa
6. North America Neurodiagnostics Market Overview
   1. Market Size and Forecast
      1. By Value (USD Million), 2020-2027
   2. Market Share and Forecast
      1. By Product
      2. By Application
      3. By End User
      4. By Country
         1. U.S.
         2. Canada
7. Europe Neurodiagnostics Market Overview
   1. Market Size and Forecast
      1. By Value (USD Million), 2020-2027
   2. Market Share and Forecast
      1. By Product
      2. By Application
      3. By End User
      4. By Country
         1. Germany
         2. U.K.
         3. France
         4. Italy
         5. Spain
         6. Rest of Europe
8. APAC Neurodiagnostics Market Overview
   1. Market Size and Forecast
      1. By Value (USD Million), 2020-2027
   2. Market Share and Forecast
      1. By Product
      2. By Application
      3. By End User
      4. By Country
         1. China
         2. India
         3. Japan
         4. South Korea
         5. Rest of APAC
9. LATAM Neurodiagnostics Market Overview
   1. Market Size and Forecast
      1. By Value (USD Million), 2020-2027
   2. Market Share and Forecast
      1. By Product
      2. By Application
      3. By End User
      4. By Country
         1. Mexico
         2. Brazil
         3. Rest of LATAM
10.  MEA Neurodiagnostics Market Overview
    1. Market Size and Forecast
       1. By Value (USD Million), 2020-2027
    2. Market Share and Forecast
    3. By Product
    4. By Application
    5. By End User
    6. By Country
       1. Saudi Arabia
       2. UAE
       3. South Africa
       4. Rest of Europe
11. Competitive Landscape
    1. List of Key Players and Their Offerings
    2. Market Share Analysis (2020)
    3. Competitive Benchmarking, By Operating Parameters
12. Impact of COVID-19 on Global Neurodiagnostics Market
13. Company Profiles (Company Overview, Financial Matrix, Key Product landscape, Key Personnel, Key Competitors, Contact Address, and Strategic Outlook) *
    1. Nihon Kohden Corporation
    2. GE Healthcare
    3. Canon Medical Systems Corporation
    4. Advanced Brain Monitoring, Inc
    5. FUJIFILM Holdings Corporation
    6. Siemens Healthineers
    7. Hoffman-La Roche AG
    8. Lifelines Neuro Company
    9. Bio-Rad Laboratories
    10. Koninklijke Philips N.V.
    11. QIAGEN N.V.
    12. Natus Medical Incorporated
    13. Fujirebio
    14. Thermo Fisher Scientific, Inc
    15. Agilent Technologies
    16. Hitachi, Ltd
    17. Ridge Diagnostics
    18. Bruker
    19. Other Prominent Players
14. Key Strategic Recommendations

List of Figures

Fig 1: Global Neurodiagnostics Segmentation

Fig 2: Global Neurodiagnostics Market Value Chain Analysis,

Fig 3: Company Market Share Analysis, 2020

Fig 4: Global Neurodiagnostics Market Size, By Value (USD Million), 2020-2027

Fig 5: Global Neurodiagnostics Market Share (%), By Product, By Value, 2020-2027

Fig 6: Global Neurodiagnostics Market Share (%), By Application, By Value, 2020-2027

Fig 7: Global Neurodiagnostics Market Share (%), By End User, By Value, 2020-2027

Fig 8: Global Neurodiagnostics Market Share (%), By Country, By Value, 2020-2027

Fig 9: North America Neurodiagnostics Market Size, By Value (USD Million), 2020-2027

Fig 10: North America Neurodiagnostics Market Share (%), By Product, By Value, 2020-2027

Fig 11: North America Neurodiagnostics Market Share (%), By Application, By Value, 2020-2027

Fig 12: North America Neurodiagnostics Market Share (%), By End User, By Value, 2020-2027

Fig 13: North America Neurodiagnostics Market Share (%), By Country, By Value, 2020-2027

Fig 14: Europe Neurodiagnostics Market Size, By Value (USD Million), 2020-2027

Fig 15: Europe Neurodiagnostics Market Share (%), By Product, By Value, 2020-2027

Fig 16: Europe Neurodiagnostics Market Share (%), By Application, By Value, 2020-2027

Fig 17: Europe Neurodiagnostics Market Share (%), By End User, By Value, 2020-2027

Fig 18: Europe Neurodiagnostics Market Share (%), By Country, By Value, 2020-2027

Fig 19: the Asia-Pacific Neurodiagnostics Market Size, By Value (USD Million), 2020-2027

Fig 20: the Asia-Pacific Neurodiagnostics Market Share (%), By Product, By Value, 2020-2027

Fig 21: the Asia-Pacific Neurodiagnostics Market Share (%), By Application, By Value, 2020-2027

Fig 22: the Asia-Pacific Neurodiagnostics Market Share (%), By End User, By Value, 2020-2027

Fig 23: the Asia-Pacific Neurodiagnostics Market Share (%), By Country, By Value, 2020-2027

Fig 24: Latin America Neurodiagnostics Market Size, By Value (USD Million), 2020-2027

Fig 25: Latin America Neurodiagnostics Market Share (%), By Product, By Value, 2020-2027

Fig 26: Latin America Neurodiagnostics Market Share (%), By Application, By Value, 2020-2027

Fig 27: Latin America Neurodiagnostics Market Share (%), By End User, By Value, 2020-2027

Fig 28: Latin America Neurodiagnostics Market Share (%), By Country, By Value, 2020-2027

Fig 29: Middle East & Africa Neurodiagnostics Market Size, By Value (USD Million), 2020-2027

Fig 30: Middle East & Africa Neurodiagnostics Market Share (%), By Product, By Value, 2020-2027

Fig 31: Middle East & Africa Neurodiagnostics Market Share (%), By Application, By Value, 2020-2027

Fig 32: Middle East & Africa Neurodiagnostics Market Share (%), By End User, By Value, 2020-2027

Fig 33: Middle East & Africa Neurodiagnostics Market Share (%), By Region, By Value, 2020-2027

List of Tables

Table 1: Global Neurodiagnostics Market Size, By Product, By Value, 2020-2027

Table 2: Global Neurodiagnostics Market Size, By Application, By Value (USD Million), 2020-2027

Table 3: Global Neurodiagnostics Market Size, By End User, By Value (USD Million), 2020-2027

Table 4: Global Neurodiagnostics Market Size, By Region, By Value (USD Million), 2020-2027

Table 5: North America Neurodiagnostics Market Size, By Product, By Value (USD Million), 2020-2027

Table 6: North America Neurodiagnostics Market Size, By Application, By Value (USD Million), 2020-2027

Table6: North America Neurodiagnostics Market Size, By End User, By Value (USD Million), 2020-2027

Table7: North America Neurodiagnostics Market Size, By Country, By Value (USD Million), 2020-2027

Table8: Europe Neurodiagnostics Market Size, By Product, By Value (USD Million), 2020-2027

Table9: Europe Neurodiagnostics Market Size, By Application, By Value (USD Million), 2020-2027

Table 10: Europe Neurodiagnostics Market Size, By End User, By Value (USD Million), 2020-2027

Table 11: Europe Neurodiagnostics Market Size, By Country, By Value (USD Million), 2020-2027

Table 12: the Asia-Pacific Neurodiagnostics Market Size, By Product, By Value (USD Million), 2020-2027

Table 13: the Asia-Pacific Neurodiagnostics Market Size, By Application, By Value (USD Million), 2020-2027

Table 14: the Asia-Pacific Neurodiagnostics Market Size, By End User, By Value (USD Million), 2020-2027

Table 15: the Asia-Pacific Neurodiagnostics Market Size, By Country, By Value (USD Million), 2020-2027

Table 16: Latin America Neurodiagnostics Market Size, By Product, By Value (USD Million), 2020-2027

Table 17: Latin America Neurodiagnostics Market Size, By Application, By Value (USD Million), 2020-2027

Table 18: Latin America Neurodiagnostics Market Size, By End User, By Value (USD Million), 2020-2027

Table 19: Latin America Neurodiagnostics Market Size, By Country, By Value (USD Million), 2020-2027

Table 20: The Middle-East & Africa Neurodiagnostics Market Size, By Product, By Value (USD Million), 2020-2027

Table 21: The Middle-East & Africa Neurodiagnostics Market Size, By Application, By Value (USD Million), 2020-2027

Table 22: The Middle-East & Africa Neurodiagnostics Market Size, By End User, By Value (USD Million), 2020-2027

Table 23: The Middle-East & Africa Neurodiagnostics Market Size, By Country, By Value (USD Million), 2020-2027

Table 24: Nihon Kohden Corporation Financial Analysis

Table 25: Nihon Kohden Corporation Business Overview

Table 26: GE Healthcare Financial Analysis

Table 27: GE HealthcareBusiness Overview

Table 28: Canon Medical Systems Corporation Financial Analysis

Table 29: Canon Medical Systems Corporation Business Overview

Table 30: Advanced Brain Monitoring, IncFinancial Analysis

Table 31: Advanced Brain Monitoring, IncBusiness Overview

Table 32: FUJIFILM Holdings CorporationFinancial Analysis

Table 33: FUJIFILM Holdings CorporationBusiness Overview

Table 34: Siemens Healthineers Financial Analysis

Table 35: Siemens Healthineers Business Overview

Table 36: Hoffman-La Roche AG Financial Analysis

Table 37: Hoffman-La Roche AG Business Overview

Table 38: Lifelines Neuro Company Financial Analysis

Table 39: Lifelines Neuro Company Corporation Business Overview

Table 40: Bio-Rad LaboratoriesFinancial Analysis

Table 41: Bio-Rad LaboratoriesBusiness Overview

Table 42: Koninklijke Philips N.V. Financial Analysis

Table 43: Koninklijke Philips N.V. Business Overview

Table 44: QIAGEN N.V. MedicalFinancial Analysis

Table 45: QIAGEN N.V. Medical Financial Analysis

Table 46: Natus Medical Incorporated Financial Analysis

Table 47: Natus Medical Incorporated Business Overview

Table 48: Fujirebio Financial Analysis

Table 49:FujirebioBusiness Overview

Table 50: Thermo Fisher Scientific, Inc Financial Analysis

Table 51: Thermo Fisher Scientific, Inc Business Overview

Table 52: Agilent Technologies Financial Analysis

Table 53: Agilent Technologies Business Overview

Table 54: Hitachi, LtdFinancial Analysis

Table 55: Hitachi, Ltd Business Overview

Table 56: Ridge Diagnostics Financial Analysis

Table 57: Ridge Diagnostics Business Overview

Table 58: BrukerFinancial Analysis

Table 59: Bruker Business Overview